A drug-test cutoff is a decision threshold used to classify a result under a defined method and program. It is not a border between ‘used’ and ‘never used,’ and it does not measure impairment, danger, or dose.
This article is part of Drug-Test Detection and Accuracy.
How a cutoff works
The laboratory or device compares its analytical response or measured concentration with a specified threshold. A result that meets the applicable criteria may advance to confirmation or be reported according to program rules. A result below the threshold is generally classified as negative for that test even if a sensitive instrument can detect a smaller amount.
Screening and confirmation cutoffs
Many programs use two stages:
- Initial testing efficiently screens specimens for a drug class or target at an initial cutoff.
- Confirmation uses a more specific method for defined analytes and applies confirmatory criteria.
The two thresholds may differ because the methods, purposes, and reportable analytes differ. It is inappropriate to compare a screening response directly with a confirmation concentration as if they were the same measurement.
Why cutoffs exist
Cutoffs help standardize classification, support reliable analytical performance, and reduce reporting of insignificant background or incidental exposure. Regulators may specify them for regulated programs, while clinical laboratories select thresholds suited to their validated methods and intended uses.
Cutoffs vary among programs
Federal workplace, DOT-regulated, nonregulated workplace, clinical, forensic, court, and home tests can use different analytes and thresholds. A result from one program cannot be reclassified using the cutoff from another without considering the method and rules.
Current federal values should be taken from the current HHS mandatory guidelines or 49 CFR Part 40 materials—not from an undated chart. Product-specific cutoffs belong in the FDA-cleared labeling or manufacturer instructions.
Cutoff versus limit of detection
The analytical limit of detection describes the smallest amount a method can reliably detect under defined conditions. The reporting cutoff is the program’s classification threshold. A method may detect an analyte below the cutoff yet correctly report the program result as negative.
Does a higher concentration mean greater impairment?
Not necessarily. Urine concentrations are affected by hydration, time, metabolism, and excretion. Hair and oral-fluid concentrations have their own limitations. Even blood concentration-to-effect relationships differ among drugs and individuals. A workplace cutoff was not designed as a universal impairment threshold.
Does a negative result mean no drug is present?
No. It means the reported analytes did not meet the test’s criteria in that specimen. The drug may be absent, below the cutoff, outside the detection window, not included in the panel, or poorly detected by the chosen method.
Questions to ask about a cutoff
- Which specimen and analyte does the number apply to?
- Is it an initial or confirmatory threshold?
- Which unit is used?
- Which regulation, laboratory method, or product labeling defines it?
- Was the specimen valid and the result confirmed when required?
- Has the governing standard been updated?
Continue with Screening Versus Confirmatory Testing and Understanding Drug-Test Results.
Sources
- SAMHSA: HHS Guidelines and Federal Testing Forms
- U.S. Department of Transportation: 49 CFR Part 40
- FDA: Drugs of Abuse Tests
Last evidence review: October 29, 2026.